BCI
BIIB icon

Brinker Capital Investments’s Biogen BIIB Stock Holding History

Brinker Capital Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$183 Buy
+1
New +$184 ﹤0.01% 1967

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brinker Capital Investments's BIIB Position: Q1 2026 in Review

Brinker Capital Investments reduced its Biogen (BIIB) stake by 26% in Q1 2026, selling an estimated $542K and leaving 8,497 shares worth $1.56M. The position accounts for 0.01% of the portfolio, ranked #884.

Brinker Capital Investments first reported a position in BIIB in Q3 2015 and has held it in 36 quarters since. The position peaked at $10.6M in Q2 2023. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Brinker Capital Investments held 8,497 shares of Biogen worth $1.56M as of Q1 2026.
  • Brinker Capital Investments sold 2,943 Biogen shares in Q1 2026, an estimated $542K.
  • Biogen made up 0.01% of Brinker Capital Investments's portfolio in Q1 2026, its #884 holding.
  • Brinker Capital Investments first reported a position in Biogen in Q3 2015 and has held it in 36 quarters since.
  • Brinker Capital Investments's Biogen position peaked at $10.6M in Q2 2023.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Brinker Capital Investments's 13F filing for Q1 2026, filed 13 May 2026.